Cartilage formed in transplants of allogeneic chondrocytes into joint cartilage defects in rats was infiltrated by immune cells migrating from the bone marrow while the surface on the side of the joint cavity remained free of infiltrations. This suggested that immunization occurred via bone marrow and not via joint cavity. Because articular cartilage is nourished exclusively by the synovial fluid, we have attempted to prevent cartilage rejection by protecting transplants from the contact with bone marrow. Defects in articular surface were filled with bone cement and chondrocytes were transplanted into a cavity prepared within the bone cement plug. Cartilage formed within the cement shell remained free of infiltrations and did not evoke systemic immunological response. However, distribution of glycosaminoglycans in the matrix of protected transplants was irregular. Cultures of chondrocytes growing in vitro on cement contained less glycosamino glycans than the controls. This suggests that some factor(s) released from the cement unfavorably influenced chondrocytes and matrix production in protected transplants.
INTRODUCTION
A variety of orthopedic pathologies or traumatic de fects affecting articular cartilage may result in serious impairment of joint function and require operative treat ment (3) . Articular cartilage has no intrinsic repair po tential (24) , and cartilage injuries that reach into sub chondral bone are usually filled by fibrous tissue formed by cells migrating from bone marrow (11, 27) . Attempts to stimulate differentiation of these cells into chondro cytes by growth factors are still at the experimental stage (16, 32, 41) . Other attempts to heal localized defects in articular cartilage have included transplantation of peri chondrium or periosteum (29, 34) , mesenchymal cells derived from various sources (19) , or osteochondral al lografts (7, 14) . In recent years autogeneic chondrocytes grown in culture have been successfully applied for healing the articular cartilage defects in humans (2) , and this approach raised considerable interest (18) . How ever, the use of autogeneic chondrocytes requires exci sion of cartilage fragment from the nonweight-bearing area, which involves additional surgical intervention and limits the number of available cells. Thus, the use of allogeneic chondrocytes for cartilage repair would be of considerable value. However, cartilage produced by al logeneic chondrocytes in articular surface defects in rats has been resorbed by infiltrating immune cells (17) and its rejection was not prevented even by strong immuno suppressive agents (33) . Nevertheless, these experiments suggested another approach aimed at the protection of recipients against sensitization by transplanted chondro cytes. All transplants were infiltrated in their deep part submerged in subchondral bone and bone marrow, while on the surface of transplants facing the joint cavity infil trating cells were absent. This observation raised the possibility that recipients of transplants were sensitized via subchondral bone and not via the joint cavity. Be cause articular cartilage is exclusively nourished by joint fluid (15, 25) , it seemed feasible to separate transplanted chondrocytes from subchondral bone and thus prevent sensitization. Indeed, cartilage formed in such trans plants was not infiltrated and resorbed but its morpho logical appearance differed considerably from intact ar ticular cartilage or cartilage formed in unprotected transplants.
MATERIALS AND METHODS
under standard conditions. Four-day-old and 5-6month-old animals served as chondrocyte donors and re cipients, respectively. All animal experimentation was approved by the Animal Ethical Committee of the Medi cal University of Warsaw. (12) .
Isolation and Transplantation of Chondrocytes

Immunological Evaluation of the Grafts
Immune reaction against transplants was evaluated by mixed spleen mononuclear cells (SMC)-chondrocytes test and antichondrocyte antibody cytotoxic test.
Mixed Chondrocyte-Splenocyte Culture
The ability of syngeneic and allogeneic chondrocytes to stimulate SMC was evaluated as described previously (17, 33) . In brief, splenocytes were mixed with chondro cytes in wells of culture plates and cultured for 96 h. 
Evaluation of Antichondrocyte Cytotoxic Antibodies
Chondrocytes labeled with Na 2 5l Cr0 4 were incubated
in twofold dilutions of the tested serum. After 1 -h incu bation rabbit complement (Biotest, D-63303 Dreieich, Germany) was added. 5l Cr radioactivity released into the medium with the tested serum as well as spontaneous (medium with complement but without serum) and max imal 5l Cr release were measured (17, 33) . Each estima tion was done in triplicate and mean cpm was taken for calculation of antichondrocyte toxicity with the formula:
% cytotoxicity = [(experimental cpm -spontaneous cpm)/ (maximal cpm -spontaneous cpm)] x 100.
Statistical Analysis
Differences between groups were evaluated by Wilcoxon matched-pairs test or by Mann-Whitney {/-test.
Estimation of Sulfated Glycosaminoglycans (GAGs)
Influence of bone cement on GAGs production was (Sigma) and 2.0 ml formic acid (Sigma) were added, and the volume was made up to 1 L with distilled water. The reagent was stored in a dark bottle at room tempera ture. GAGs were determined separately in cells remain ing in wells and in the medium. For each determination done in triplicate 25 pi of sample solution was pipetted with vigorous mixing into 250 pi of DMB solution, and the absorbance was read immediately at 535 nm in a spectrophotometer (Auto EIA, Labsystems, Finland). The amount of GAGs was computed from the standard curve prepared with chondroitin sulfate A (Sigma).
Counting of Cells and Estimation of Their Viability
Cells from control and cement-containing cultures were detached by collagenase solution and rinsed in PBS. The number of cells was estimated in a Biirker's chamber. Cell viability was determined by trypan blue (Sigma) exclusion test according to the protocol sup plied by the manufacturer.
RESULTS
Unprotected Chondrocyte Transplants
Cartilage formed by isolated syngeneic (Fig. la) and allogeneic chondrocytes in unprotected transplants filled the defect and had similar microscopic appearance as described previously (17, 30, 33) . Superficial chondro cytes were flattened, like in intact articular cartilage ( Fig. 2a, b ), while in deep zone numerous chondrocytes 
Protected Transplants, General Features
The presence of the cement plug did not evoke any evident inflammatory reaction in the joint. The mobility of the rats was not impaired. The borders of the plug adhered tightly to the articular cartilage and were usu ally slightly elevated over its level (Fig. lb) . The tissue filling the cavity within the plug was often below its rim but occasionally reached over it, covering the peripheral cement. After removal of the fixed tissue cell detritus remained at the bottom of the cavity, but the presence of blood was never observed.
Protected Transplants, Microscopic Observations
Morphology of the tissue formed in allogeneic trans plants did not differ from that of syngeneic ones and therefore they will be described jointly. The transplants removed from the cement shell frequently contained some acellular material at the bottom. The cells were nonhomogenously distributed ( Fig. 3a, b ). The surface of the transplants was usually covered by a layer of a proteinaceous material. Infiltrating cells at the surface or Deeper in the transplant the cell density was lower and the cells frequently occurred singly (Fig. 4a, c) . At the bottom of transplants some eosinophilic material devoid of cells or only with sparse cells was present. In sections stained with toluidine blue positive reaction was seen only in some areas of transplants (Fig. 4b) . In superficial area, with large groups of cells, staining was usually weak or absent. The only difference between 3-and 8week-old transplants was some increase in the amount of toluidine blue-positive material in the latter.
Evaluation of Antichondrocyte Immune Response
Like in the previous reports (17, 33) , SMC from recip ients of unprotected allogeneic transplants were stimu lated by allogeneic chondrocytes. The response was con siderably stronger after 3 weeks than after 8 weeks posttransplantation. Response of SMC from recipients of protected allogeneic transplants did not differ from that of intact animals and recipients of syngeneic trans plants ( Fig. 5 ).
Cytotoxic activity against chondrocytes was present in sera of intact animals and recipients of syngeneic transplants, like in the previous studies (17, 33) . Cyto toxic activity was significantly increased in sera of un protected allogeneic transplant recipients and remained at the control level in animals with protected transplants (Fig. 6 ).
Influence of Bone Cement on Chondrocyte Culture
Chondrocytes in control wells grew in monolayers. Figure 6 . Antichondrocyte cytotoxicity of sera from chondrocyte recipients. Cytotoxicity of all sera was compared at the dilution of 1:32 because it was always in the linear part of the dose-response curve. Each bar represents the mean ± SE. In all groups n = 6. The difference in cytotoxic activity of sera against syngeneic and allogeneic chondrocytes within a particular group was estimated by Wilcoxon matched-pairs test. The significance of difference between cytotoxic activity of sera from various experimental groups was tested by Mann-Whitney U-test.
Chondrocytes cultured in wells containing bone
cell with collagenase exceeded in control cultures 95% and in cement cultures 90%. GAG content of cultures grown in wells with bone cement was significantly lower than in controls ( Fig. 7) .
DISCUSSION
Protected transplants, contrary to unprotected ones, did not evoke specific cellular or humoral general im munological response and were not destroyed by infil trating cells, although the number of transplanted chon drocytes was similar in both types of transplants. These observations are in good agreement with the assumption that allogeneic chondrocytes transplanted into defects created in articular cartilage sensitize the recipient via subchondral bone and not by contact with immunologi cally competent synovial cells. Synovium contains bone marrow-derived macrophages and occasionally also den dritic cells (9, 36, 43) , which are antigen-presenting cells (42) . Intra-articular sensitization induces a strong sys temic immune response (37) . Moreover, intra-articular injection of antigens in naive or preimmunized animals leads to inflammatory arthritis and cartilage damage (6, 8, 39, 40) . Thus, synoviocytes most probably could process chondrocyte antigens serving as the first link necessary for sensitization via the joint cavity. Chondro cytes were, however, suspended in a highly viscous hya luronic acid, which probably prevented their dispersion within the joint cavity and contact with synoviocytes. Subsequent formation of cartilage matrix would restore its protective function (1, 23, 31) . Chondrocytes in trans plants would be sequestered from the immunocompetent cells present in the synovium, similarly as in transplants of allogeneic cartilage fragments. Such transplants may survive for a long period both in soft tissues (13) and within joints as shell allografts (articular cartilage with a thin shell of underlying bone) (5, 26, 28) .
The appearance of tissue produced by protected chondrocytes considerably differed from the normal ar ticular cartilage or cartilage in unprotected transplants.
The superficial chondrocytes formed groups of several cells and were rounded instead of flattened. Further more, GAGs, detected by toluidine blue staining were present only in some areas of the transplants. Mature articular cartilage is separated from the subchondral bone by the calcified zone (38) and is exclusively nour ished by synovial fluid (15, 25) , which also stimulates In both groups n = 6. Each bar represents mean + SE. The dif ference between bars, according to Mann-Whitney [/-test, is significant at p < 0.005. manner (21) . Thus, the separation of transplants from the underlying bone should not affect their metabolism, and the differences in appearance of protected and un protected transplants were most probably caused by other factor(s).
To ensure separation of transplants from bone mar row we have attempted in pilot experiments to cover walls of the defects in the articular cartilage and under lying bone with a layer of bone cement. Good separation was never achieved and some blood was usually visible beneath the transplants, indicating leakage. Complete filling of defects with cement and formation of the cav ity within the cement plugs solved the problem of trans plant separation, but it was difficult to level the plugs with the surface of cartilage. Consequently, in most cases the cement slightly protruded over the joint sur face and the transplant was slightly submerged in it. Thus, surface of cartilage in protected transplants might not be in contact with surface of the patella, which could explain why the superficial chondrocytes were rounded and not flattened. Furthermore, protected transplants contained less GAGs than unprotected ones. Because proteoglycan synthesis by chondrocytes is influenced both by static compression (4) and cyclic loading (20) it is possible that the lack of contact between articular sur faces affected proteoglycan content in protected trans plants. Nevertheless, it could have also been caused by a factor released from the cement. Indeed, in cultures of chondrocytes seeded on a cement layer, GAG content of such cultures was lower than in controls. It seems proba ble that a factor present in the liquid component was not completely bound by the cement powder and was re leased into the medium, thus affecting metabolism of chondrocytes.
The question remains whether prevention of sensiti zation by mechanical barrier between bone marrow and chondrocytes could be obtained in large animals and in humans. It is also uncertain whether technical problems intrinsic to protected transplants would allow use of this approach in clinical practice. Bone cement is not optimal for barrier formation because it influences metabolism of chondrocytes. However, once protection of allogeneic chondrocyte transplants by mechanical separation is documented, efforts to find better materials might be justified. The main difficulty probably would be forma tion of a protecting layer reaching only to the level of articular cartilage-endochondral bone junction. More over, the transplant should not be too thick, because its bottom would become necrotic. Nevertheless, the use of allogeneic chondrocytes would offer an obvious advan tage because the need to excise a fragment of autologeneic cartilage would be eliminated. The number of avail able cells, particularly if embryonic cartilage was used, would be much greater and this procedure could be used in patients whose own cartilage is too degenerated to yield healthy chondrocytes. Thus, this approach de serves serious consideration.
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